However, prior clinical studies [18,19] attempting to investigate the relationship between EGFR mutations and radiosensitivity in NSCLC patients with brain metastases did not reach unanimous conclusions, mostly due to the lack of coordinated follow-up. This evidence concerns the gene EGFR and non-small cell lung carcinoma.